Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study

44Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

Objective: To unravel the perspective of patients with rheumatoid arthritis (RA) on preferred health and treatment outcomes at 2 time points during the early stage of their disease and treatment. Methods: In a longitudinal, qualitative, explorative study, we individually interviewed 26 patients with early RA (ERA) 4–6 months after the start of initial RA treatment. Fourteen of these participants took part in 1 of 3 focus groups at least 1 year after treatment initiation. Interviews were audiotaped, transcribed verbatim, and analyzed using the constant comparison method. Two patient researchers completed the interdisciplinary research team. Results: Patients with ERA ultimately strive to be normal again, literally and figuratively. Outcome preferences inherent to this urge for normality were related to aspects of disease control, physical aspects, aspects of participation, and mental aspects. Initially, patient outcome preferences in ERA were primarily related to pain relief, medication side effects and burden, and emotional well-being. Patient-preferred outcomes evolved over the ERA disease course, with subtle changes in terminology used by participants and with pain relief staying in the foreground. Conclusion: From a patient perspective, normality is the ultimate outcome to target in ERA. Our study produced knowledge for designing more targeted therapeutic interventions aimed at normalizing patients’ health and life in all its aspects during a crucial phase of RA.

References Powered by Scopus

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

19364Citations
N/AReaders
Get full text

Qualitative Research: Consensus methods for medical and health services research

2723Citations
N/AReaders
Get full text

Patient-centredness: A conceptual framework and review of the empirical literature

2124Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: The phase 3, randomised controlled FINCH 3 trial

104Citations
N/AReaders
Get full text

Establishing outcome measures in early knee osteoarthritis

101Citations
N/AReaders
Get full text

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

91Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

van der Elst, K., Meyfroidt, S., De Cock, D., De Groef, A., Binnard, E., Moons, P., … Westhovens, R. (2016). Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study. Arthritis Care and Research, 68(9), 1278–1287. https://doi.org/10.1002/acr.22824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

67%

Researcher 8

30%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

60%

Psychology 4

16%

Pharmacology, Toxicology and Pharmaceut... 3

12%

Nursing and Health Professions 3

12%

Save time finding and organizing research with Mendeley

Sign up for free